卵巢被单一覆盖层的表层上皮细胞所覆盖，这层细胞在体内的形态由鳞状上皮变化成低柱状立方形。OSEpiC参与周期性排卵卵泡破裂和随后的修复。OSEpiC表达大量的多肽类激素，性激素，生长因子和受体。这些众多的生物物质与卵巢上皮癌和性传播疾病的发**展有关。研究相应细胞通路的畸变可以了解OSEpiC的生长、凋亡、转化和在疾病发生时的功能及潜在的标记物质，这些可以为**治疗疾病提供非常重要的信息。
Sciencell研究实验室的HOSEC是从人卵巢分离得到的，原代冻存，冰冻运输。每管细胞密度*过5×10^5/ml。细胞特性经cytokeratine-14, -18, and -19免疫荧光鉴定。本细胞经检测不含HIV-1、HBV、HCV、支原体、细菌、酵母菌和真菌。如采用ScienCell?实验室特制的培养基，可保证此细胞5倍增增殖。
推荐培养基：卵巢上皮细胞培养基?(OEpiCM, Cat. #7311)
|
货号
|
7310
|
|
产地
|
美国
|
|
缩写
|
HOSEpiC
|
|
规格
|
5 x 10^5 /1ml
|
|
用途
|
科研
|
|
储存
|
液氮
|
|
运输
|
干冰
|
1.) Takahashi Y, Koyanagi T, Suzuki Y, Saga Y, Kanomata N, Moriya T, Suzuki M, Sato Y. (2012) "Vasohibin-2 expressed in human serous ovarian adenocarcinoma accelerates tumor growth by promoting angiogenesis."?Mol Cancer Res. 10: 1135-46.
2.) Semaan A, Qazi AM, Seward S, Chamala S, Bryant CS, Kumar S, Morris R, Steffes CP, Bouwman DL, Mukarah AR, Weaver DW, Gruber SA, Batchu RB. (2011) "MicroRNA-101 Inhibits Growth of Epithelial Ovarian Cancer by Relieving Chromatin-Mediated Transcriptional Repression of p21waf1/cip1."?Pharm Res. 28: 3079-90.
3.) Guo AM, Liu X, Al-Wahab Z, Maddippati KR, Ali-Fehmi R, Scicli AG, Munkarah AR. (2011) "Role of 12-lipoxygenase in regulation of ovarian cancer cell proliferation and survival."?Cancer ChemotherPharmacol.68: 1273-83.
4.) Selvendiran K, Ahmed S, Dayton A, Kuppusamy ML, Tazi M, Bratasz A, Tong L, Rivera BK, K?lai T, Hideg K, Kuppusamy P. (2010) "Safe and targeted anticancer efficacy of a novel class of antioxidant-conjugated difluorodiarylidenyl piperidones: differential cytotoxicity in healthy and cancer cells."?Free Radic Biol Med. 48: 1228-35.?
5.) Selvendiran K, Tong L, Bratasz A, Kuppusamy ML, Ahmed S, Ravi Y, Trigg NJ, Rivera BK, K?lai T, Hideg K, Kuppusamy P. (2010) "Anticancer efficacy of a difluorodiarylidenyl piperidone (HO-3867) in human ovarian cancer cells and tumor xenografts."?Mol Cancer Ther. 9: 1169-79.
6.) Selvendiran K, Ahmed S, Dayton A, Kuppusamy ML, Tazi M, Bratasz A, Tong L, Rivera BK, Kalai T, Hideg K, Kuppusamy P. (2010) "Safe and targeted anticancer efficacy of a novel class of antioxidant-conjugated difluorodiarylidenylpiperidones: differential cytotoxicity in healthy and cancer cells."?Free RadicBiol Med.48: 1228-35.
?
There are no product questions yet.
